Last Posted: Feb 13, 2020
- Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
Seven Memnun et al. Cancer nursing 2020 Jan - Genetic testing in young women with breast cancer: results from a Web-based survey.
Ruddy K J et al. Annals of oncology : official journal of the European Society for Medical Oncology 2010 Apr 21(4) 741-7 - Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program.
Hao Jing et al. Journal of personalized medicine 2020 Feb 10(1) - Oncology Clinic-Based Hereditary Cancer Genetic Testing in a Population-Based Health Care System.
Richardson Matthew et al. Cancers 2020 Feb 12(2) - Risk-Reducing Bilateral Salpingo-Oophorectomy for BRCA Mutation Carriers and Hormonal Replacement Therapy: If It Should Rain, Better a Drizzle than a Storm.
Gasparri Maria Luisa et al. Medicina (Kaunas, Lithuania) 2019 Jul 55(8) - Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
Eleje George U et al. The Cochrane database of systematic reviews 2018 8CD012464 - BRCA1 & BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
Apostolou Paraskevi et al. International journal of cancer 2020 Feb - Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population.
da Costa E Silva Carvalho Simone et al. BMC medical genomics 2020 Feb 13(1) 21 - Characteristics predicting recommendation for familial breast cancer referral in a cohort of women from primary care.
Lee Siang Ing et al. Journal of community genetics 2020 Jan - Genetic Cancer Risk Assessment: a screenshot of the psychosocial profile of women at risk for Hereditary Breast and Ovarian Cancer Syndrome.
Campacci Natalia et al. Psycho-oncology 2020 Jan
.jpeg)
No hay comentarios:
Publicar un comentario